ModernaTX, Inc. et al v. Pfizer Inc. et al
Case Number:
1:22-cv-11378
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 12, 2024
Moderna, Pfizer COVID Vax IP Suit Paused Amid PTAB Review
A Massachusetts federal judge on Friday agreed to pause Moderna Inc.'s COVID-19 vaccine patent infringement suit against Pfizer Inc. and BioNTech until the Patent Trial and Appeal Board weighs in on a pair of patents, issuing a stay despite objections from Moderna.
-
April 10, 2024
Moderna Says Pfizer Is PTAB 'Tea-Leaf-Reading' In Vax IP Row
Moderna Inc. asked a Boston federal judge to deny Pfizer Inc.'s bid to pause a COVID-19 vaccine patent trial while the Patent Trial and Appeal Board reviews the validity of two of the three patents at issue.
-
March 28, 2024
Pfizer Wants Moderna Vax IP Case Paused For PTAB Review
Pfizer Inc. and BioNTech SE have asked a Massachusetts federal court to put on hold a COVID-19 vaccine patent case brought by rival biotechnology giant Moderna Inc. while they await a decision from the Patent Trial and Appeal Board on the validity of two of the three patents at issue.
-
February 07, 2024
Pfizer, Moderna Spar Over Trial Date In COVID Vaccine IP Case
Moderna and Pfizer are battling over setting a trial date in a dispute in Massachusetts federal court over COVID-19 vaccine patent infringement claims, with Pfizer looking to schedule a trial after summary judgment motions are decided, while Moderna is arguing a firm trial date is needed now and should be set for this fall.
-
January 22, 2024
Moderna Wants UPenn Biochemist's Emails In Vax IP Dispute
Moderna has asked a federal judge to order a University of Pennsylvania biochemist to turn over a set of emails and documents that could be relevant to an underlying COVID vaccine-related patent dispute with rival biotech giants Pfizer and BioNTech.
-
January 16, 2024
Pfizer Calls Moderna 'Willfully Naïve' In Covid Vax IP Fight
Pfizer and BioNTech have told the Patent Trial and Appeal Board not to rely on the timing of district court patent litigation to reject their challenges to a pair of Moderna COVID vaccine patents, arguing that the company relied on "cherry-picked data" and is acting "willfully naïve."
-
December 11, 2023
Moderna Says Pfizer COVID Vax Patent Challenges Fail Fintiv
Moderna has urged the Patent Trial and Appeal Board not to review its COVID-19 vaccine patents challenged by rivals Pfizer and BioNTech, saying a related district court trial will likely end before the board's decision is due, and the petitions don't show that the patents are invalid.
-
November 02, 2023
Moderna Blasts Pfizer Bid To Add Defense To Patent Row
Moderna has urged a Massachusetts federal judge to deny a bid by Pfizer and BioNTech to file an amended response in a suit over COVID-19 patents, saying their proposed contrast defense doesn't have any "legitimate basis."
-
August 28, 2023
Pfizer Takes Aim At Moderna COVID Vaccine Patents At PTAB
Pfizer and BioNTech on Monday filed Patent Trial and Appeal Board challenges to two of the three Moderna COVID-19 vaccine patents they have been accused of infringing, saying the "unimaginably broad" claims of the patents are invalid as anticipated and obvious.
-
August 01, 2023
Judge Backs Moderna On Key Patent Terms In Pfizer Vax Row
A Massachusetts federal judge on Tuesday mostly sided with Moderna's interpretation of important phrases found in the COVID-19 vaccine patents that the company accuses Pfizer and BioNTech of infringing in a high-stakes dispute.